Link: Shareholder Alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Juno Therapeutics Inc.
The news of the trial's suspension sent Juno's stock down more than 30 percent. Juno Therapeutics, which is based in Seattle, reported it to the Food and Drug Administration. That's done by genetically modifying a patient's immune T cells to attack the cancer. But the method can produce severe side-effects, including immune system overreactions and neurological toxicity - like the brain-swelling that proved fatal in this trial. A number of other companies, including Kite Pharma and Novartis, are also developing CAR-T treatments.
While the company is still investigating these deaths, the culprit seems to be a chemotherapy drug called fludarabine. Juno CEO Hans Bishop said his company and the FDA agreed that a "change at the time was not warranted", because they did not believe the death was related to the treatment. All three of these patients were also on a pre-conditioning regimen of fludarabine. The notice to temporarily halt the biotechnology startup's heavily funded clinical trial came after three patients died during the process. Specifically, it suggests a combination of a current standard of care chemotherapy drug called fludarabine and the company's experimental CART candidate JCAR015 is the root of the edemas. "It's unfortunate, but I don't know how you avoid it", Dr Otis Brawley, chief medical officer for the American Cancer Society, told AP. In response to the hold, Juno plans to omit fludarabine from the trial, which is known as ROCKET, and will provide a complete response to the FDA this week. One investor said it's risky to change an experimental protocol like that and questioned whether the move, meant to improve the efficacy of the manipulated T cells, was too aggressive. Before allowing the company to do so, the FDA asked that Juno submit a raft of revised materials, including patient consent forms, investigator brochures, and the trial protocol. Juno has been studying many similar gene-altering immunotherapies for different types of leukemia and expects its first approval in early 2018. While Juno may be successful in this effort, the bigger issue is that Kite and Juno's lead therapies are probably going to be relegated to the status of later lines of treatment, in the best-case scenario, due to these lingering safety concerns.
Juno stock had actually closed Thursday's trading at $40.82, rising more than two percent. Investors were apparently concerned that Juno's problems could portend more regulatory scrutiny or other difficulties for the entire field.
A Juno Therapeutics Inc trial of its experimental cancer therapy, known as JCAR015, was put on hold by US regulators after the deaths last week of two leukemia patients, the company said on Thursday. As these super-charged T-cells reproduce and spread throughout the body, they identify, bind to, and destroy the cancerous cells.
US biotechnology company Juno Therapeutics Inc (NASDAQ:JUNO) collapsed on Wall Street after announcing that two patients undergoing clinical trials of its experimental treatment against leukemia have died.
Two leukemia patients involved in the trial died last week, while a third passed away in May.
Writing his weekly column in the Daily Telegraph , Mr Johnson said: "There were more than 16 million who wanted to remain". Polling for The Times meanwhile suggested Theresa May has overtaken Boris Johnson as Tories' favourite.
Brian Williams, a surgeon at Parkland hospital, was in charge of the emergency room the night of the Dallas police shooting. Williams went on to call for "open discussions" on race relations in the hopes it will bring people together.
Candidates for Labour leadership need the backing of 50 MPs to appear on the ballot, which Corbyn is unlikely to receive. The party's ruling National Executive Committee will tomorrow meet to discuss the timing and operation of the contest.
The live broadcast begins airing on ESPN and MLB.com at 8pm ET tonight. "I'm going to enjoy every second of it and just enjoy it". His 20 home runs rank him fifth among the players in Monday's competition, but he might have more power than anyone in baseball.
The U.S. government last week imposed penalties on Kim and 10 other top officials for alleged human rights abuses. The two Koreas have been divided along the world's most heavily fortified border since the 1950-53 Korean War.
The biotechnology startup has appealed to the FDA to continue the clinical trials without the use of fludarabine. Now, this is the important part. "This sort of thing is incredibly common in new drug development".
There are other airfields in Mosul and in Tal Afar city, west of Mosul, but both are in Islamic State-held territory. The Iraqi Prime Minister Haider al-Abadi has reportedly pledged to retake Mosul for ISIS militants by the year's end.
County officials said the mare was able to survive the infection and that the animal is now recovering from the disease slowly. It is important to prevent areas that can serve as a backyard breeding area for mosquitoes, as well, he said .
There were hints in that game of Duncan's plans, even though he later exercised a contract option to clear the way for his return. Future NBA Hall of Famer Tim Duncan will retire after 19 seasons, the San Antonio Spurs said in a statement Monday.
Numerous newly deployed troops will be based at an airfield 40 miles south of Mosul that was reclaimed by Iraqi soldiers Saturday. But one of the senior defense officials said they would be especially useful closer to Mosul for complex operations.
In second was " The Legend of Tarzan ", which took in $20.61 million , giving it a domestic total of around $81 million. It continues Illumination's unbroken streak of having all its films open No. 1 at the box office.
Aerosmith's Joe Perry collapses in concert
The band is scheduled to play in Kettering, Ohio, on July 12, although it remains to be seen whether Perry will be fit to perform. He is stable right now, with family & is under the best care", the Hollywood Vampires vocalist, 68, tweeted Sunday night.
North Korea threatens over US missile system in South Korea
Pyongyang said it would make a " physical response " following the deployment of the advanced THAAD missile defence system. The two countries are technically still at war after the 1950-53 conflict ended in an armistice instead of a peace treaty.